RankAlpha logo
Back to Rankings

DHR

DanaherD
NYSE / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-02
View Chart
+
Peers tracked
10
U.S. public peers
Grade Position
Below peers
vs peer average
DHR vs peer average
31/100
DHR vs. peer average (D vs. C)
Grade spread
A 1 · B 2 · C 5 · D 2
Graded peers loaded
Coverage
10 graded
100% of tracked

Peer overview

A is the first available peer comparator.

Agilent overlaps with Danaher in analytical instruments and diagnostics-adjacent workflows, helping test whether Danaher's Life Sciences recovery is company-specific or part of a broader lab-tools normalization.

✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
Top peerAAgilent
DHR
Danaher
A
Agilent
Grade
D
D
Momentum
18
47
Value
62
62
Sentiment
44
33
Setup Bias
Net Neutral
-
Market Cap
-
-
Posture
Defensive
Defensive
Open Side-by-Side ComparisonCompare all

Grade position vs A

DHR / A
Grade Position
Below peers
DHR vs. peer average (D vs. C)
31/100
Momentum
18
A
Value
62
DHR
Sentiment
44
DHR

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs DHR
1
A
A
D
40/100
Even
2
TMO
TMO
B
80/100
-2
3
WAT
WAT
A
100/100
-3
4
BMY
Bristol-Myers Squibb Co Common
C
60/100
-1
5
VRTX
Vertex Pharmaceuticals Inc Common
B
80/100
-2
A is the first peer returned for this comparison set.